Evidence map›Paper›PMID 42840144›Full record

ArticleFrontiers in endocrinology2026

Factors associated with diabetic retinopathy: a cross-sectional study of 1477 patients across four cities in Anhui, China.

Yanlei Wang, Liya Ai, Pan Yang, Ying Xing, Huaiyu Lin, Shumin Wang, Guilong Sun, Ying Zhang, Liping Xue, Tian Jiang and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yanlei Wang *Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Liya Ai *Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Pan YangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Ying XingDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Huaiyu LinDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Shumin WangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Guilong SunDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Ying ZhangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Liping XueDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Tian JiangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Qiu ZhangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yi ZhangDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetic retinopathy (DR) remains the leading cause of blindness among working-age adults. With the rising prevalence of diabetes, the burden of DR continues to escalate, substantially impairing patients' quality of life. Identifying clinical factors associated with prevalent DR may help refine risk-based ophthalmic assessment. Using a large cross-sectional dataset, this study examined associations between routinely available clinical indicators and the presence of DR. Particular attention was given to heart rate (HR), an understudied and readily available vital sign, and to diabetes treatment histories. Methods: Leveraging data from the China DiaChronic Study, this cross-sectional analysis included data from 1,477 patients with diabetes. Categorical variables (sex, smoking and alcohol status, education) were analyzed by chi-square tests; continuous variables by independent-samples t-tests or Wilcoxon rank-sum tests. Binary logistic regression estimated factors associated with prevalent DR after adjustment for demographic, metabolic, diabetes-duration, and treatment-history variables; variance inflation factors (VIFs) were used to assess multicollinearity; ROC curves described cross-sectional discrimination; formal interaction terms assessed whether selected associations differed by HbA1c category; and Spearman correlation assessed relationships between HbA1c and other parameters. Results: Among 1,477 patients, 259 (17.5%) had DR. After additional adjustment for diabetes duration and medication histories, higher systolic blood pressure (SBP), heart rate (HR), HbA1c, blood urea nitrogen (BUN), urinary albumin-creatinine ratio (UACR), and longer diabetes duration were associated with prevalent DR (all Conclusion: Higher SBP, HR, HbA1c, BUN, UACR, and longer diabetes duration were associated with prevalent DR after multivariable adjustment. Among these, the association with HR is the most potentially novel and may reflect cardiac autonomic dysfunction rather than a direct causal effect. Although HbA1c and UACR showed only modest cross-sectional discrimination, the findings support integrated cardiometabolic, renal, and diabetes-history assessment to complement guideline-recommended retinal screening. Prospective validation is warranted.

Indexed as

Diabetic RetinopathyAdultAgedChinaCitiesCross-Sectional StudiesFemaleGlycated HemoglobinHeart RateHumansMaleMiddle AgedPrevalenceRisk FactorsGlycated Hemoglobinassociated factorscross-sectional studydiabetic retinopathyHbA1cUACR

Identifiers

PMID42840144
PMCPMC13638506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.